Wednesday, March 25, 2015 – 12pm CST Speaker: Sonali M. Smith, MD Click Here to Register
Wednesday, March 18, 2015 – 12PM CST Speaker: John P. Leonard, MD – Associate Dean for Clinical Research, Weill Cornell Medical College Click Here to Register
Friday, March 6, 2015 – 2pm CST Speakers: Deborah K. Mayer, PhD, RN, AOCN, FAAN Jennifer R. Klemp, PhD, MPH Alicia Rosales, LCSW, OSW-C Click Here to Register
Zarxio is approved for the same indications as Neupogen. Click Here for Biosimilars Information for Consumers
The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.